A recent analytical research paper out of Italy titled, Preventive Vitamin D Supplementation and Risk for COVID-19 Infection: A Systematic Review and Meta-Analysis, “... suggests a definitive and significant association between the protective role of vitamin D and COVID-19 incidence and ICU admission.” …
Read MoreReaders are urged to review an important paper by Dr. John P. A. Ioannidis published back in 2005 (but even more relevant today given the problematic origin of certain novel diseases and the unbridled politicization of public health care), the opening paragraph of which includes the unsettling statement: It can be proven that most claimed research findings are false. …
Read MoreThe following narrative describes a curious situation in the pharmaceutical industry whereby (a) liver dysfunction and myopathy contraindications specifically linked to statin-induced depletion of serum CoQ10 are clearly stated in two 1990 Merck patents, (b) the ameliorative products described in the patents were never marketed, and (c) the specific linkage between said contraindications and CoQ10 depletion is obfuscated in subsequent pharmaceutical literature. …
Read MoreReaders are advised that in 2006, Boeing obtained a patent for a system that could assume control of an aircraft from a remote location with or without the transfer of control being directed or authorized by the pilot. …
Read MoreIn Part 1, it was argued that the incorporation of any version of the Maneuvering Characteristics Augmentation System (MCAS) or any other form of ancillary automation to compensate for a problematic aerodynamic integration aspect of the 737 MAX design, rendered the 737 MAX non-compliant in respect of the (Stall characteristics) 14 CFR 25.203(a) requirement to “promptly prevent stalling and to recover from a stall by normal use of controls.” …
Read MoreOn August 6, 2020, the Federal Aviation Administration (FAA) posted Document ID FAA-2020-0686-0001 (see https://www.regulations.gov/document/FAA-2020-0686-0001) apprising the public of a proposed Airworthiness Directive (AD) to supersede Airworthiness Directive 2018-23-51 (applicable to all The Boeing Company Model 737-8 and 737-9 (737 MAX) airplanes), the agency having determined that final corrective action would be necessary to address the unsafe condition. The agency stated that comments on the proposed AD must be received no later than September 21, 2020.
Read More